MedRisk

View the org chart displaying its 7 main executives

Most searched biographies at MedRisk

• Srivatsan Sridharan, Chief Executive Officer
• Michael Ryan, Executive Chairman of the Board
• John Jakovčić, Chief Technology Officer

Popular executive movements at MedRisk

• Srivatsan Sridharan, who was Chief Client Officer, is promoted to Chief Executive Officer  (posted on September 19 2023).

Create your alert
to follow the executive moves at MedRisk.

MedRisk has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Lucia Aleotti - Director at Menarini Group
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by MedRisk

• Company News | MedRisk
• Company News | MedRisk

Social media about MedRisk

• MedRisk on Wikipedia, Google News & Yahoo Finance
• MedRisk on LinkedIn, Twitter & YouTube

Contact by email its executives including Srivatsan Sridharan

Call MedRisk at +1 800...

View the org chart

Register to receive your alert

Report an error